{"entity":{"type":"insider","cik":"0001410781","url":"/insider/0001410781","json_url":"/insider/0001410781.json","name":"JOHNSON JOHN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":14,"first":"2007-09-10","last":"2026-06-05","span_basis":"filed_date"},"name_variants":[{"name":"JOHNSON JOHN","source":"filing","n_filings":13,"first_seen":"2011-09-16","last_seen":"2026-06-05"},{"name":"Johnson John H","source":"filing","n_filings":1,"first_seen":"2007-09-10","last_seen":"2007-09-10"}],"transactions":[{"id":6020492,"accession":"0001410781-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001410781-26-000004","line_url":"/filing/0001410781-26-000004#line-2","is_derivative":false,"issuer_cik":"0001410781","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001410781","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":6.0948,"price_display":"6.09","price_state":"stated","total_value":91422.0,"total_display":"91,422.00","total_whole":"91,422","shares_owned_after":683083.0,"shares_owned_after_display":"683,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-05","scope":"insider"},{"id":5823293,"accession":"0001410781-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001410781-26-000002","line_url":"/filing/0001410781-26-000002#line-2","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11050.0,"shares_display":"11,050","price_per_share":43.255,"price_display":"43.26","price_state":"stated","total_value":477967.75,"total_display":"477,967.75","total_whole":"477,968","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-07","filed_date":"2026-05-08","scope":"insider"},{"id":4035380,"accession":"0001410781-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001410781-25-000006","line_url":"/filing/0001410781-25-000006#line-1","is_derivative":false,"issuer_cik":"0001410781","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001410781","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135400.0,"shares_display":"135,400","price_per_share":7.2158,"price_display":"7.22","price_state":"stated","total_value":977019.32,"total_display":"977,019.32","total_whole":"977,019","shares_owned_after":698083.0,"shares_owned_after_display":"698,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-19","scope":"insider"},{"id":5078940,"accession":"0001410781-25-000004","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001410781-25-000004","line_url":"/filing/0001410781-25-000004","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21686.0,"shares_display":"21,686","price_per_share":29.982,"price_display":"29.98","price_state":"stated","total_value":650189.652,"total_display":"650,189.65","total_whole":"650,190","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-10","scope":"insider","n_lines":2},{"id":5078929,"accession":"0001410781-25-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001410781-25-000004","line_url":"/filing/0001410781-25-000004","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23693.0,"shares_display":"23,693","price_per_share":31.241430506900773,"price_display":"31.24","price_state":"stated","total_value":740203.213,"total_display":"740,203.21","total_whole":"740,203","shares_owned_after":13141.0,"shares_owned_after_display":"13,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider","n_lines":2},{"id":4361141,"accession":"0001867096-25-000141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-25-000141","line_url":"/filing/0001867096-25-000141#line-1","is_derivative":false,"issuer_cik":"0001410781","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001410781","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107500.0,"shares_display":"107,500","price_per_share":7.3159,"price_display":"7.32","price_state":"stated","total_value":786459.25,"total_display":"786,459.25","total_whole":"786,459","shares_owned_after":833483.0,"shares_owned_after_display":"833,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-15","scope":"insider"},{"id":4042786,"accession":"0000805928-25-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000805928-25-000081","line_url":"/filing/0000805928-25-000081#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4073.0,"shares_display":"4,073","price_per_share":10.61,"price_display":"10.61","price_state":"stated","total_value":43214.53,"total_display":"43,214.53","total_whole":"43,215","shares_owned_after":24943.0,"shares_owned_after_display":"24,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-11","scope":"insider"},{"id":8628823,"accession":"0001461993-19-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001461993-19-000037","line_url":"/filing/0001461993-19-000037#line-1","is_derivative":false,"issuer_cik":"0001410781","issuer_name":"MELINTA THERAPEUTICS, INC. /NEW/","issuer_ticker":"MLNT","issuer_name_source":null,"issuer_url":"/issuer/0001410781","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Melinta Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":5.5724,"price_display":"5.57","price_state":"stated","total_value":72441.2,"total_display":"72,441.20","total_whole":"72,441","shares_owned_after":37400.0,"shares_owned_after_display":"37,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-27","filed_date":"2019-07-02","scope":"insider"},{"id":6526953,"accession":"0001209191-14-037445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-037445","line_url":"/filing/0001209191-14-037445#line-1","is_derivative":false,"issuer_cik":"0001410781","issuer_name":"CEMPRA, INC.","issuer_ticker":"CEMP","issuer_name_source":null,"issuer_url":"/issuer/0001410781","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.098,"price_display":"9.10","price_state":"stated","total_value":90980.0,"total_display":"90,980.00","total_whole":"90,980","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-23","filed_date":"2014-05-28","scope":"insider"},{"id":3433750,"accession":"0001181431-12-000642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-000642","line_url":"/filing/0001181431-12-000642#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17650.0,"shares_display":"17,650","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":40595.0,"total_display":"40,595.00","total_whole":"40,595","shares_owned_after":252350.0,"shares_owned_after_display":"252,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-04","scope":"insider"},{"id":8994324,"accession":"0001181431-11-057425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-057425","line_url":"/filing/0001181431-11-057425#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":11500.0,"total_display":"11,500.00","total_whole":"11,500","shares_owned_after":270000.0,"shares_owned_after_display":"270,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-21","filed_date":"2011-11-22","scope":"insider"},{"id":9044595,"accession":"0001181431-11-057051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-057051","line_url":"/filing/0001181431-11-057051","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":2.2872545454545454,"price_display":"2.29","price_state":"stated","total_value":25159.8,"total_display":"25,159.80","total_whole":"25,160","shares_owned_after":265000.0,"shares_owned_after_display":"265,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-18","filed_date":"2011-11-21","scope":"insider","n_lines":2},{"id":9126423,"accession":"0001209191-11-054796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-054796","line_url":"/filing/0001209191-11-054796#line-1","is_derivative":false,"issuer_cik":"0001107332","issuer_name":"DENDREON CORP","issuer_ticker":"DNDN","issuer_name_source":null,"issuer_url":"/issuer/0001107332","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":6.6756,"price_display":"6.68","price_state":"stated","total_value":16689.0,"total_display":"16,689.00","total_whole":"16,689","shares_owned_after":12943.0,"shares_owned_after_display":"12,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-04","filed_date":"2011-11-07","scope":"insider"},{"id":9141535,"accession":"0001181431-11-049676","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-049676","line_url":"/filing/0001181431-11-049676","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26500.0,"shares_display":"26,500","price_per_share":4.099150943396227,"price_display":"4.10","price_state":"stated","total_value":108627.5,"total_display":"108,627.50","total_whole":"108,628","shares_owned_after":255000.0,"shares_owned_after_display":"255,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-16","filed_date":"2011-09-16","scope":"insider","n_lines":2},{"id":9141533,"accession":"0001181431-11-049676","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-049676","line_url":"/filing/0001181431-11-049676#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001410781","owner_name":"JOHNSON JOHN","owner_display_name":"JOHNSON JOHN","owner_url":"/insider/0001410781","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":3.8825,"price_display":"3.88","price_state":"stated","total_value":5823.75,"total_display":"5,823.75","total_whole":"5,824","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-14","filed_date":"2011-09-16","scope":"insider"},{"id":8366832,"accession":"0001104659-07-067965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-07-067965","line_url":"/filing/0001104659-07-067965#line-1","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001410781","owner_name":"Johnson John H","owner_display_name":"Johnson John H","owner_url":"/insider/0001410781","role":"Officer (CEO)","role_mark":"O","role_mark_label":"Officer (CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13609.0,"shares_display":"13,609","price_per_share":36.74,"price_display":"36.74","price_state":"stated","total_value":499994.66,"total_display":"499,994.66","total_whole":"499,995","shares_owned_after":13609.0,"shares_owned_after_display":"13,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-07","filed_date":"2007-09-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001867096","name":"Xeris Biopharma Holdings, Inc.","url":"/issuer/0001867096","role":"Director","n_filings":3,"first_seen":"2025-08-15","last_seen":"2026-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000805928","name":"Axogen, Inc.","url":"/issuer/0000805928","role":"Director","n_filings":3,"first_seen":"2025-06-11","last_seen":"2026-05-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001461993","name":"MELINTA THERAPEUTICS, INC. /NEW/","url":"/issuer/0001461993","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2014-05-28","last_seen":"2019-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0000722104","name":"SAVIENT PHARMACEUTICALS INC","url":"/issuer/0000722104","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2011-09-16","last_seen":"2012-01-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001107332","name":"DENDREON CORP","url":"/issuer/0001107332","role":"Director","n_filings":1,"first_seen":"2011-11-07","last_seen":"2011-11-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000765258","name":"IMCLONE SYSTEMS INC","url":"/issuer/0000765258","role":"Officer (CEO)","n_filings":1,"first_seen":"2007-09-10","last_seen":"2007-09-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001410781","retrieved_at":"2026-08-23T08:24:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}